Trial · NCT01606072
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Selection of the higher safe dose level for ensuing clinical trials | Up to 2 years | One of the three dose levels assessed in this study will be selected for further clinical testing in adults: 0,50 mg, 1,0 mg, 1,25 mg, 1,5 mg or 2,0 mg. |
| Secondary | Evidence of V2 Receptor Expression | Baseline | |
| Secondary | Evidence of CTC (CIRCULATING TUMOR CELLS) | Baseline | |
| Secondary | Evidence of Von Willebrand factor antigen (VWF:Ag) | Baseline | |
| Secondary | Evidence of CTC (circulating tumor cells) | 30 minutes pre surgery and 24 hours post the surgery | |
| Secondary | Evidence of CTC (circulating tumor cells) | 2 Weeks | |
| Secondary | Evidence of CTC (circulating tumor cells) | 1 Month | |
| Secondary | Evidence of CTC (circulating tumor cells) | 3 Months | |
| Secondary | Evidence of CTC (circulating tumor cells) | 6 Months | |
| Secondary | Evidence of CTC (circulating tumor cells) | 12 Months | |
| Secondary | Evidence of Von Willebrand factor antigen (VWF:Ag) | 120 minutes post the surgery | |
| Secondary | Evidence of VWF activity (ristocetin cofactor, VWF:RCo) | baseline | |
| Secondary | Evidence of VWF activity (ristocetin cofactor, VWF:RCo) | 120 minutes post the surgery | |
| Secondary | Evidence of FVIII coagulant activity (FVIII:C) | baseline | |
| Secondary | Evidence of FVIII coagulant activity (FVIII:C) | 120 minutes post the surgery | |
| Secondary | Evidence of euglobulin lysis time | baseline | |
| Secondary | Evidence of euglobulin lysis time | 120 minutes post the surgery |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01606072/registered